Dr Rischin on the Efficacy of Adjuvant Cemiplimab in High-Risk CSCC | OncLive
Dr Rischin on the Efficacy of Adjuvant Cemiplimab in High-Risk CSCC | OncLive
7 months ago
onclive.com
What is LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
What is LIBTAYO® (cemiplimab-rwlc) | Advanced CSCC
Feb 26, 2021
libtayo.com
CSCC Treatment Options: Cemiplimab and Pembrolizumab | OncLive
CSCC Treatment Options: Cemiplimab and Pembrolizumab | OncLive
Apr 19, 2023
onclive.com
Regeneron Pharmaceuticals, Inc.: Libtayo (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery ...
Regeneron Pharmaceuticals, Inc.: Libtayo (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery ...
7 months ago
finanznachrichten.de
Sanofi: premières données positives pour le Libtayo dans le cancer de la peau
Sanofi: premières données positives pour le Libtayo dans le cancer de la peau
May 4, 2020
lesechos.fr
Regeneron Pharmaceuticals: EMA-Ausschuss gibt positives Votum für Libtayo (Cemiplimab) als adjuvante Therapie bei CSCC
Regeneron Pharmaceuticals: EMA-Ausschuss gibt positives Votum für Libtayo (Cemiplimab) als adjuvante Therapie bei CSCC
7 months ago
marketscreener.com
Regeneron Pharmaceuticals, Inc.: Libtayo (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
Regeneron Pharmaceuticals, Inc.: Libtayo (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
11 months ago
finanznachrichten.de
Regeneron Pharmaceuticals, Inc.: Adjuvant Libtayo (cemiplimab) Significantly Improves Disease-Free Survival (DFS) After Surgery in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) in Phase 3 Trial
Jan 13, 2025
finanznachrichten.de
31:57
Episode 110: Treating Advanced Skin Cancer Without Surgery: Hedgehog & PD-1 Inhibitors
23 views3 weeks ago
YouTubeThe Science of Skin Podcast
12:13
Updates on T-cell engagers and CARs in CLL: liso-cel, novel agents, and resistance mechanisms
106 views2 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:27
Phio Pharmaceuticals Corp. recently participated in the VIC Life Sciences Investor Forum - Clip 4
50 views2 weeks ago
YouTubeB2i Digital, Inc.
22:07
How to Treat Small Cell Lung Cancer (SCLC) – Treatment Algorithm with Dr. Jacob Sands
2.9K views2 weeks ago
YouTubeOncBrothers: Practice-Changing Cancer Discu…
1:21
Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a B2i Digital Featured Company, recently presented at the Virtual Investor Conferences Life Sciences Investor Forum. In the clip below, President and CEO… | David Shapiro
1 month ago
linkedin.com
13:36
Pharmacology - CANCER DRUGS – CELL CYCLE INHIBITORS (MADE EASY)
216.4K viewsMar 1, 2020
YouTubeSpeed Pharmacology
0:52
Benefit With Cemiplimab in Patients With mCSCC
491 viewsDec 13, 2018
YouTubeTargeted Oncology
3:25
ESC TV at ACC.18 - Two carvedilol cardiotoxicity trials
5.3K viewsMar 11, 2018
YouTubeEuropean Society of Cardiology
11:33
CAR-T Cell Therapies for CLL: How are the various techniques different?
37.7K viewsNov 24, 2015
YouTubeHMP Education
6:56
$
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
14.3K viewsMar 10, 2018
jove.com
7:47
$
A Proteoliposome-Based Efflux Assay to Determine Single-molecule Properties of Cl- Channels and Transporters
10K viewsApr 20, 2015
jove.com
5:45
VADEMECUM - Libtayo (Cemiplimab)
11 views1 month ago
YouTubeUn Farmacéutico
7:22
Advanced/Metastatic cSCC Treatment Options
1.6K viewsFeb 5, 2019
YouTubeOncLive
4:51
Advanced CSCC: The New Systemic Therapy
535 viewsOct 31, 2018
YouTubeTargeted Oncology
5:55
Calculating CCα and CCβ
1.7K viewsNov 2, 2016
YouTubeValidation of liquid chromatography mass spect…
4:02
CYP metabolism & inhibition assays
2.7K viewsJan 6, 2021
YouTubeChem Help ASAP
7:10
Evolving CLL Treatment in 2025
3K viewsMay 14, 2025
YouTubeBlood Cancers Today
4:13
Cemiplimab in Managing Advanced cSCC
940 viewsJun 4, 2019
YouTubeTargeted Oncology
8:20
Ep. 3 - Day 1 of Treatment!
712 views7 months ago
YouTubeMatt Murrell
4:37
CcdA/CcdB Toxin-Antitoxin System
11.3K viewsMay 23, 2017
YouTubeNCSU BIT
4:50
Novel BCL2 inhibitors in CLL: sonrotoclax and lisaftoclax
234 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
14:32
Systemic Therapy For Nonmelanoma Skin Cancer and Emerging Research
2.5K viewsOct 27, 2023
YouTubeAIM at Skin Cancer Foundation
See more